Biotech, Cell & Gene Therapies: Risk Based Approach To ATMPs

Biotech, Cell & Gene Therapies: Risk Based Approach To ATMPs
Following on from the successful series of webinars on ATMPs in 2021, Dr Bridget Heelan returns with an updated presentation on the risk based approach to ATMPs.






Date: Thursday 31 October 2024
Time: 12:00–13:00 GMT / 13:00–14:00 CET
Location: Online

Speaker

Bridget Heelan has over 16 years of regulatory experience, as VP (tech) at Parexel and prior to that as Senior Clinical Assessor at MHRA.  Chair of CHMP Rheumatology Immunology Working Party at EMA and UK delegate to the Committee for advanced Therapies.

She is a Consultant immunologist and head of laboratory and clinical services at the University Hospitals in London (Royal Free and Barts and the London)

 

Agenda

  1. Introduction by Dr Jayne Hunt FTOPRA, Chair of the TOPRA Biotech SPIN Group
  2. Presentation by Bridget Heelan, M.B. D.Phil. Regulatory Consultant, Parexel
  3. Q & A session

 

Pricing  

  • TOPRA Members: Free  
  • Non-member: £45:00

 

How to register

Members:

  • Use the 'Register now' form above to log in to the site with your TOPRA Member username and password.
  • Once logged in click the 'Register Myself' button that will appear below.

Non-members:

  • If you already have non-member account for this site, log in and then click the 'Register Myself' link that will appear below.
  • If you do not have an account, create an account, then log in and click the 'Register Myself' link that will appear below.
 
When
31/10/2024 12:00 - 13:00
Where
ONLINE
Registration is closed
My registration status: Not registered
Your company name
Your VAT country
Your VAT number
NOTE
Important instructions before booking - If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email finance@topra.org

Register now